• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒受体及相关基因的变异与特定类型的人乳头瘤病毒感染及宫颈病变进展相关。

Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.

作者信息

Zou Jian, Cao Zhu, Zhang Jianyang, Chen Tingting, Yang Shizhou, Huang Yongjie, Hong Die, Li Yang, Chen Xiaojing, Wang Xinyu, Cheng Xiaodong, Lu Weiguo, Xie Xing

机构信息

The Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China.

Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China.

出版信息

Oncotarget. 2016 Jun 28;7(26):40135-40147. doi: 10.18632/oncotarget.9510.

DOI:10.18632/oncotarget.9510
PMID:27223085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5129998/
Abstract

Human papillomavirus (HPV) infects cervical epithelial cells through cellular membrane receptors, and then induces the initiation and progression of cervical cancer. Single nucleotide polymorphisms (SNPs) may impact the susceptibility and outcome of diseases, but it's still unknown whether variant in HPV receptor and associated genes is associated with type-specific HPV infection and cervical lesion progression. We examined 96 SNPs in 8 genes which may participate in the HPV infection process in 875 samples with HPV negative or single HPV16, 18, 52, 58 positive from 3299 cervical exfoliated cell samples, by Illumina BeadXpress VeraCode platform, and analyzed the correlation between the SNPs and type-specific HPV infection and cervical lesions progression. We found rs28384376 in EGFR and rs12034979 in HSPG2 significantly correlated to HPV16 infection; rs2575738, rs2575712, rs2575735 in SDC2 and rs6697265 in HSPG2 significantly correlated to HPV18 infection; rs10510097 in FGFR2, rs12718946 in EGFR significantly correlated to HPV52 infection; rs4947972 in EGFR, rs2981451 in FGFR2, rs2575735 in SDC2 significantly correlated to HPV58 infection. And rs3135772, rs1047057 and rs2556537 in FGFR2, rs12034979 in HSPG2, rs16894821 in SDC2 significantly correlated to cervical lesion progression induced by HPV16 infection; rs6697265 and rs6680566 in HSPG2, rs16860426 in ITGA6 by HPV18 infection; rs878949 in HSPG2, rs12718946 and rs12668175 in EGFR by HPV52 infection; no SNP by HPV58 infection. Our findings suggest that HPV receptor and associated gene variants may influence the susceptibilities to HPV type-specific infection and cervical lesion progression, which might have a potential application value in cervical cancer screening and therapy.

摘要

人乳头瘤病毒(HPV)通过细胞膜受体感染宫颈上皮细胞,进而诱发宫颈癌的发生与发展。单核苷酸多态性(SNP)可能会影响疾病的易感性和转归,但HPV受体及相关基因的变异是否与特定型别HPV感染及宫颈病变进展相关仍不清楚。我们通过Illumina BeadXpress VeraCode平台,对来自3299份宫颈脱落细胞样本中的875份HPV阴性或单一HPV16、18、52、58阳性样本的8个可能参与HPV感染过程的基因中的96个SNP进行了检测,并分析了这些SNP与特定型别HPV感染及宫颈病变进展之间的相关性。我们发现,EGFR基因中的rs28384376和HSPG2基因中的rs12034979与HPV16感染显著相关;SDC2基因中的rs2575738、rs2575712、rs2575735以及HSPG2基因中的rs6697265与HPV18感染显著相关;FGFR2基因中的rs10510097、EGFR基因中的rs12718946与HPV52感染显著相关;EGFR基因中的rs4947972、FGFR2基因中的rs2981451、SDC2基因中的rs2575735与HPV58感染显著相关。并且,FGFR2基因中的rs3135772、rs1047057和rs2556537,HSPG2基因中的rs12034979,SDC2基因中的rs16894821与HPV16感染所致的宫颈病变进展显著相关;HSPG2基因中的rs6697265和rs6680566,ITGA6基因中的rs16860426与HPV18感染相关;HSPG2基因中的rs878949,EGFR基因中的rs12718946和rs12668175与HPV52感染相关;HPV58感染未发现相关SNP。我们的研究结果表明,HPV受体及相关基因变异可能影响对HPV特定型别感染的易感性及宫颈病变进展,这在宫颈癌筛查和治疗中可能具有潜在应用价值。

相似文献

1
Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.人乳头瘤病毒受体及相关基因的变异与特定类型的人乳头瘤病毒感染及宫颈病变进展相关。
Oncotarget. 2016 Jun 28;7(26):40135-40147. doi: 10.18632/oncotarget.9510.
2
The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.人乳头瘤病毒受体相关遗传变异在宫颈癌筛查中的意义。
Microbiol Spectr. 2023 Aug 17;11(4):e0511722. doi: 10.1128/spectrum.05117-22. Epub 2023 Jun 26.
3
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].[不同HPV亚型感染合并细胞学异常状态下CIN2+/CIN3+风险的评估]
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015.
4
High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.中国农村人群高危型人乳头瘤病毒基因型分布及其与宫颈癌和癌前病变的关系
J Gynecol Oncol. 2017 Jul;28(4):e30. doi: 10.3802/jgo.2017.28.e30.
5
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.人乳头瘤病毒(HPV)DNA在良性和发育异常宫颈组织中的物理状态及表达:不同水平的病毒整合与病变分级相关。
Gynecol Oncol. 2004 Mar;92(3):873-80. doi: 10.1016/j.ygyno.2003.11.035.
6
Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.人乳头瘤病毒感染的分布:江苏省宫颈样本的基于人群的研究。
Virol J. 2019 May 20;16(1):67. doi: 10.1186/s12985-019-1175-z.
7
Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.日本细胞学异常女性人乳头瘤病毒感染的疫苗接种前流行病学情况
J Obstet Gynaecol Res. 2011 Nov;37(11):1666-70. doi: 10.1111/j.1447-0756.2011.01601.x. Epub 2011 Jul 27.
8
HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study.中国广东省珠江三角洲地区女性的人乳头瘤病毒基因型及相关宫颈细胞学异常:一项横断面研究
BMC Infect Dis. 2014 Jul 12;14:388. doi: 10.1186/1471-2334-14-388.
9
The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.人乳头瘤病毒16型(HPV16)感染的物理状态及其在癌前病变和宫颈癌中的临床意义。
J Cancer Res Clin Oncol. 2008 Dec;134(12):1355-61. doi: 10.1007/s00432-008-0413-3. Epub 2008 May 14.
10
[Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].[人乳头瘤病毒分型检测在子宫颈癌前病变和子宫颈癌筛查中的性能]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):252-256. doi: 10.3760/cma.j.cn112152-20190603-00346.

引用本文的文献

1
Metagenomic insight into the vaginal microbiome in women infected with HPV 16 and 18.对感染人乳头瘤病毒16型和18型的女性阴道微生物群的宏基因组学见解。
NPJ Biofilms Microbiomes. 2025 Jun 12;11(1):105. doi: 10.1038/s41522-025-00747-1.
2
A multi-variable predictive warning model for cervical cancer using clinical and SNPs data.一种利用临床和单核苷酸多态性(SNP)数据构建的宫颈癌多变量预测预警模型。
Front Med (Lausanne). 2024 Feb 22;11:1294230. doi: 10.3389/fmed.2024.1294230. eCollection 2024.
3
Is an oropharyngeal HPV infection more frequently detectable in women with a genital HPV infection?口咽 HPV 感染在生殖道 HPV 感染的女性中是否更易被检出?
Eur Arch Otorhinolaryngol. 2024 Feb;281(2):1041-1046. doi: 10.1007/s00405-023-08314-0. Epub 2023 Nov 10.
4
The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.人乳头瘤病毒受体相关遗传变异在宫颈癌筛查中的意义。
Microbiol Spectr. 2023 Aug 17;11(4):e0511722. doi: 10.1128/spectrum.05117-22. Epub 2023 Jun 26.
5
The Alterations of Vaginal Microbiome in HPV16 Infection as Identified by Shotgun Metagenomic Sequencing.通过鸟枪法宏基因组测序鉴定HPV16感染中阴道微生物群的改变
Front Cell Infect Microbiol. 2020 Jun 23;10:286. doi: 10.3389/fcimb.2020.00286. eCollection 2020.
6
Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma.口咽癌治疗后HPV表面刷检与复发风险
Cancers (Basel). 2020 Apr 25;12(5):1069. doi: 10.3390/cancers12051069.
7
Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells.宫颈癌组织和 SiHa 细胞的转录组测序图谱。
Funct Integr Genomics. 2020 Mar;20(2):211-221. doi: 10.1007/s10142-019-00706-y. Epub 2019 Aug 27.
8
HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.HPV 表观遗传机制与口咽癌和宫颈癌的关系。
Cancer Biol Ther. 2018;19(10):850-857. doi: 10.1080/15384047.2017.1310349. Epub 2018 May 14.
9
The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection.使用快速且具有成本效益的血液生物标志物,结合肿瘤TNM分期,用于个体头颈癌患者的治疗选择。
Med Oncol. 2017 Apr;34(4):63. doi: 10.1007/s12032-017-0912-7. Epub 2017 Mar 18.

本文引用的文献

1
FIGO Cancer Report 2015.《国际妇产科联盟2015年癌症报告》
Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S75. doi: 10.1016/j.ijgo.2015.06.024.
2
NTCP opens the door for hepatitis B virus infection.钠-牛磺胆酸共转运体(NTCP)为乙型肝炎病毒感染打开了大门。
Antiviral Res. 2015 Sep;121:24-30. doi: 10.1016/j.antiviral.2015.06.002. Epub 2015 Jun 10.
3
The biology of human papillomaviruses.人乳头瘤病毒的生物学
Curr Probl Dermatol. 2014;45:19-32. doi: 10.1159/000355959. Epub 2014 Mar 13.
4
HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.宫颈癌中HPV-16 E2的体内物理状态及分子进化
Int J Biol Markers. 2014 Mar 24;29(1):e78-85. doi: 10.5301/jbm.5000051.
5
Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.多个肝素硫酸结合位点的结合是人类乳头瘤病毒 16 型感染进入所必需的。
J Virol. 2013 Nov;87(21):11426-37. doi: 10.1128/JVI.01721-13. Epub 2013 Aug 21.
6
The evolving field of human papillomavirus receptor research: a review of binding and entry.人乳头瘤病毒受体研究的演进领域:结合和进入的综述。
J Virol. 2013 Jun;87(11):6062-72. doi: 10.1128/JVI.00330-13. Epub 2013 Mar 27.
7
The molecular basis of HIV entry.HIV 进入的分子基础。
Cell Microbiol. 2012 Aug;14(8):1183-92. doi: 10.1111/j.1462-5822.2012.01812.x. Epub 2012 Jun 5.
8
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.115789 例 HPV 阳性妇女中的人乳头瘤病毒类型:从宫颈感染到癌症的荟萃分析。
Int J Cancer. 2012 Nov 15;131(10):2349-59. doi: 10.1002/ijc.27485. Epub 2012 Mar 20.
9
Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.宫颈癌筛查中人乳头瘤病毒检测:适应证和方法学评价。
Cancer Cytopathol. 2011 Aug 25;119(4):219-27. doi: 10.1002/cncy.20161. Epub 2011 Jun 29.
10
Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens.Cervista HPV HR 检测的临床应用:56501 例标本的细胞学和 HPV 状态相关性。
J Mol Diagn. 2011 Mar;13(2):160-6. doi: 10.1016/j.jmoldx.2010.11.016.